RESUMEN
INTRODUCTION: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during reproductive age. It is characterized clinically by oligo-ovulation or anovulation, hyper-androgenism, and the presence of polycystic ovaries. Often comorbid with insulin resistance, dyslipidemia, and obesity, it also carries significant risk for the development of cardio-vascular and metabolic sequelae, including diabetes and metabolic syndrome. In light of these evidences, the most therapeutic option prescribed to PCOS women with obesity, regardless of the phenotype from the severity of clinical expression, is lifestyle correction by diet and physical activity. PURPOSE: The aim of this study was to evaluate the association between PCOS with KD in overweight and/or obese women with PCOS, and evaluate the possible beneficial effects on metabolic and endocrine parameters, compared to a standard, balanced hypocaloric diet such as Mediterranean diet (MD). METHODS: Participants were assigned to receive, in a 1:1 ratio, one of the two following dietary sequences: KD or MD. In all subjects anthropometric parameters, body composition and metabolic and endocrine parameters were obtained at baseline and after dietetic treatment. RESULTS: Our results showed a significant change in the anthropometric and biochemical parameters in both groups after both diet therapies, with statistically significant differences (p < 0.001). Though, the reductions of all parameters were significantly greater in KD group than in MD group. CONCLUSION: Our results suggest that a reduction of dietary intake of carbohydrates by KD may be considered as a valuable non-pharmacological treatment for PCOS.
Asunto(s)
Dieta Cetogénica , Dieta Mediterránea , Resistencia a la Insulina , Síndrome del Ovario Poliquístico , Humanos , Femenino , Obesidad/complicaciones , Obesidad/terapia , Síndrome del Ovario Poliquístico/complicaciones , Síndrome del Ovario Poliquístico/terapia , Síndrome del Ovario Poliquístico/metabolismo , Sobrepeso/complicaciones , Sobrepeso/terapia , Dieta ReductoraRESUMEN
The application of nutraceuticals in the field of male sexual function -in particular for erectile dysfunction (ED)--remains relatively underexplored. In a group of 54 unselected men (35-75 years), consecutively presenting to our ED clinic and naive to other ED treatments, we carried out a single-blind, one-arm study to evaluate the effects of a 3-month supplementation with propionyl-L-carnitine, L-arginine and niacin on their sexual performance. All patients had the short-international index of erectile function (IIEF) questionnaire, global assessment questions (GAQs) and routine laboratory testing, at baseline and 3 months afterward. 51 (92%) patients of 54 completed the entire study period. After 3 months of treatment, a small, but statistically significant improvement in total and single items of the IIEF was found (Δ = 5.7 ± 4.1 P < 0.01). Analyses on GAQs revealed that treatment improved erections in 40% of cases, with a partial response occurring in up to 77% of subjects enrolled. These preliminary findings indicate that the favourable cardiovascular effects of nutraceuticals might also reflect on male sexual function with possible implication in the treatment and prevention of ED. This study documents a considerable patient's interest toward nutritional supplementation--as first-line or adjunctive treatment to PDE5 inhibitors--that goes beyond the measurable increment in penile rigidity.
Asunto(s)
Arginina/uso terapéutico , Carnitina/análogos & derivados , Suplementos Dietéticos , Disfunción Eréctil/tratamiento farmacológico , Niacina/uso terapéutico , Adulto , Anciano , Carnitina/uso terapéutico , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Germline mutations in the gene encoding the tumour suppressor E-cadherin (CDH1) are the underlying genetic defect responsible for hereditary diffuse gastric cancer (HDGC). A remarkably high percentage ( approximately 80%) of CDH1 mutations in HDGC patients and carriers generate premature termination codons (PTCs). Here, we examined whether CDH1 transcripts harbouring PTCs are downregulated by nonsense-mediated decay (NMD), an RNA surveillance pathway that degrades PTC-bearing transcripts. Using an allele-specific expression (ASE) assay to differentiate between mutated and wild-type CDH1 alleles, we found that PTC-bearing CDH1 mRNAs are strongly downregulated in normal gastric tissue from several CDH1 mutation carriers. We show that NMD is responsible for this robust downregulation, as CDH1 transcripts harbouring PTCs in the KATO-III gastric tumour cell line were upregulated in response to protein synthesis inhibitors or depletion of the NMD factors UPF1 and eIF4AIII. Analysis of HDGC patients harbouring CDH1 alleles with PTCs at a wide variety of different positions indicates an association of their predicted ability to induce NMD and an earlier age of onset of gastric cancer. This suggests that NMD may be detrimental for HDGC patients and therefore NMD is a potentially useful therapeutic target for CDH1 mutation carriers.
Asunto(s)
Cadherinas/genética , Estabilidad del ARN/fisiología , ARN Mensajero/metabolismo , Transducción de Señal/fisiología , Neoplasias Gástricas/genética , Adulto , Edad de Inicio , Anciano , Antígenos CD , Secuencia de Bases , Cadherinas/metabolismo , Codón sin Sentido/genética , Codón sin Sentido/fisiología , Regulación hacia Abajo , Factor 4A Eucariótico de Iniciación/genética , Factor 4A Eucariótico de Iniciación/fisiología , Mutación de Línea Germinal , Heterocigoto , Humanos , Persona de Mediana Edad , ARN Helicasas , Estabilidad del ARN/genética , ARN Mensajero/genética , Neoplasias Gástricas/metabolismo , Transactivadores/genética , Transactivadores/fisiología , Células Tumorales CultivadasRESUMEN
We report a 3-year-old boy with isolated 3-methylcrotonyl-coenzyme A deficiency with unexpectedly severe presentation, seizures and history of cerebral ischae-mic episode.
Asunto(s)
Errores Innatos del Metabolismo de los Aminoácidos/complicaciones , Errores Innatos del Metabolismo de los Aminoácidos/diagnóstico , Ligasas de Carbono-Carbono/deficiencia , Accidente Cerebrovascular/complicaciones , Errores Innatos del Metabolismo de los Aminoácidos/terapia , Preescolar , Glicina/análogos & derivados , Glicina/orina , Humanos , Masculino , Fenotipo , Valeratos/orinaRESUMEN
We report the association of CDH1/E-cadherin mutations with cleft lip, with or without cleft palate (CLP), in two families with hereditary diffuse gastric cancer (HDGC). In each family, the CDH1 mutation was a splicing mutation generating aberrant transcripts with an in-frame deletion, removing the extracellular cadherin repeat domains involved in cell-cell adhesion. Such transcripts might encode mutant proteins with trans-dominant negative effects. We found that CDH1 is highly expressed at 4 and 5 weeks in the frontonasal prominence, and at 6 weeks in the lateral and medial nasal prominences of human embryos, and is therefore expressed during the critical stages of lip and palate development. These findings suggest that alteration of the E-cadherin pathway can contribute to human clefting.
Asunto(s)
Cadherinas/genética , Labio Leporino/genética , Fisura del Paladar/genética , Mutación/genética , Neoplasias Gástricas/genética , Adulto , Análisis Mutacional de ADN , Perfilación de la Expresión Génica , Humanos , LinajeRESUMEN
We describe a patient who was evaluated because of delayed development. The patient had microcephaly and cafe-au-lait spots and the facial features included upward slanting of the palpebral fissures, short nasal bridge and a highly arched palate. In addition the external ears had bilateral over folded helices, there was clinodactyly of the fourth and fifth fingers and multiple cafe-au-lait spots on the back, buttocks and thighs. Chromosomal analysis of peripheral blood showed 46,XY,-r(12)(p13.3q24.33)[73]/45,XY,-12[8]/47,XY,r(12)(p13.3q24.33),+r(12)(p13.3q24.33)[2]. This is the eighth case of a patient with a ring chromosome 12 to be reported so far. The similarity of our patient to those previously described suggests that the ring chromosome 12 syndrome can be delineated as a distinct entity with characteristic clinical features.
Asunto(s)
Anomalías Múltiples/genética , Manchas Café con Leche/patología , Cromosomas Humanos Par 12/genética , Microcefalia/patología , Cromosomas en Anillo , Anomalías Múltiples/patología , Niño , Bandeo Cromosómico , Discapacidades del Desarrollo/patología , Oído/anomalías , Dedos/anomalías , Humanos , Cariotipificación , Masculino , SíndromeRESUMEN
We report a boy with possible Proteus syndrome and precocious puberty. This appears to be the first report of this association.
Asunto(s)
Síndrome de Proteo/complicaciones , Pubertad Precoz/complicaciones , Niño , Humanos , Masculino , Síndrome de Proteo/diagnóstico por imagen , Tomografía Computarizada por Rayos XRESUMEN
Cerebello-trigemino-dermal "dysplasia" is a rare neurocutaneous syndrome of craniosynostosis, ataxia, trigeminal anesthesia, scalp alopecia, cerebellar anomaly, midface hypoplasia, corneal opacities, apparently low-set ears, mental retardation, and short stature. It seems to be a sporadic condition but little is known about its cause and pathogenesis in the few cases reported so far. We present three new unrelated patients and magnetic resonance images of the central nervous system, and review the four cases reported previously. We think that this is not such a rare condition, and that it is underdiagnosed.